title: Research supports the view that sentinel node biopsy is the standard of care in high-risk primary melanoma.
authors.forename: Lutz
authors.initials: L
authors.lastname: Kretschmer
authors.forename: Reinhard
authors.initials: R
authors.lastname: Hilgers
mesh_terms: D006801:Humans; D008197:Lymph Node Excision; D008545:Melanoma / Q000473:pathology* / Q000601:surgery; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000473:pathology* / Q000601:surgery